Skip to main content
Clinical Trials/CTRI/2024/07/069739
CTRI/2024/07/069739
Not yet recruiting
Phase 3

Comparative evaluation of implant stability quotient and marginal bone loss in conventional and Ultraviolet light photofunctionalized dental implant retained mandibular overdenture in patients with moderately controlled Diabetes Mellitus a randomized controlled clinical study - nil

Dr Harshal Jain0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: K081- Complete loss of teeth
Sponsor
Dr Harshal Jain
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr Harshal Jain

Eligibility Criteria

Inclusion Criteria

  • a Subjects 18 years and above
  • b Completely edentulous upper and lower arches
  • c Edentulous ridge classification as per American College of Prosthodontists (ACP) type III \& type lV
  • d Able to provide consent
  • e Patients with moderately controlled type 2 diabetes mellitus
  • f HbA1C value 6\.9\-8\.0
  • g Patients whose consent for surgical placement of implants is obtained from physician treating them for diabetes

Exclusion Criteria

  • a Patients with systemic diseases or metabolic disorders other than diabetes if any which may impact study
  • b Patients is currently a smoker or quit smoking less than 1 year
  • c Pregnant and lactating women
  • d Patients in whom bone grafting is indicated along with the placement of implants
  • e Patients in whom immediate implants are placed
  • f Patients who have received or are on chemotherapy or radiotherapy or drugs that interfere with implant integration
  • g Patients having any surgical or congenital mandibular defects

Outcomes

Primary Outcomes

Not specified

Similar Trials